【作者(必填)】
Pratley RE, Nauck MA, Bailey T, et al.
【文题(必填)】
Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial.
【年份(必填)】
Diabetes Care, 2012,35:1986-1993.
【全文链接或数据库名称(选填)】
http://www.ncbi.nlm.nih.gov/pubmed/?term=Exenatide+once+weekly+for+the+treatment+of+type+2+diabetes+mellitus%3A+clinical+results+in+subgroups+of+patients+using+different+concomitant+medications